Thymomas, rare immune-associated neoplasms, present clinical challenges due to their aggressive nature and poor response to oncology treatments. Further research is needed to confirm their pathogenic link with immune system disorders.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: